Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

ARM's Powerful Ecosystem Advantage Drives Market LeadershipPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
ARM's Powerful Ecosystem Advantage Drives Market Leadership

Arm Holdings plc ARM has built a formidable competitive advantage through a deeply interconnected ecosystem that effectively unites software developers and hardware manufacturers. This powerful

PayPal Stock Trades at Discount Valuation: How to Play the Stock
PayPal Stock Trades at Discount Valuation: How to Play the Stock

PayPal Holdings PYPL shares are trading cheap, as suggested by the Value Score of A. In terms of forward 12-month price-to-earnings (P/E), PayPal is currently trading at 8.18X, lower than the Zacks

Can an Expanding Clientele Boost ServiceNow's Top-Line Growth?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/3967c11c-b755-4d39-87d0-acc853384c80.png
Can an Expanding Clientele Boost ServiceNow's Top-Line Growth?

ServiceNow NOW is benefiting from an expanding enterprise clientele, driven by rising AI-driven workflow demand. Deeper platform penetration across large organizations is a key catalyst. The

Lemonade Stock Plunges 16% in 3 Months: Time to Buy the Dip?
Lemonade Stock Plunges 16% in 3 Months: Time to Buy the Dip?

Shares of Lemonade LMND have lost 15.9% in the past three months, underperforming the industry, the Finance sector and the Zacks S&P 500 composite.Lemonade offers renters, homeowners, pet, car and

VRT vs. APH: Which AI Infrastructure Stock Is the Smarter Buy Now?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7835e381-fcae-4834-ba93-4708292dc055.png
VRT vs. APH: Which AI Infrastructure Stock Is the Smarter Buy Now?

Vertiv VRT and Amphenol APH are major players in the AI and data center infrastructure market, supplying critical power, cooling and connectivity solutions used in hyperscale and enterprise data

ACGL's Solid Growth Comes With a Premium Valuation: Hold or Buy?Photo, wide shot, wide-angle lens, soft focus,  Risk management company, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-vkrXsXVXnZepYEkiT4BvjtCA.png?st=2023-05-14T13%3A27%3A43Z&se=2023-05-14T15%3A27%3A43Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-14T00%3A09%3A01Z&ske=2023-05-15T00%3A09%3A01Z&sks=b&skv=2021-08-06&sig=y1VhH4rrtYGKSVOHO3rBwhpmvE42GCwp7%2BKdLaLI7kA%3D
ACGL's Solid Growth Comes With a Premium Valuation: Hold or Buy?

Shares of Arch Capital Group Ltd.ACGL are trading at a premium to the Zacks Property and Casualty Insurance industry. Its price-to-book value of 1.43X is higher than the industry average of 1.33X

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates
ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

ProKidney Corp. (PROK) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.13 per share a year ago. These figures

Is Realty Income Stock a Buy After Q1 Results, or Still a Hold Now?
Is Realty Income Stock a Buy After Q1 Results, or Still a Hold Now?

Realty Income’s O recently released first-quarter results gave investors a familiar mix: steady rent collection, dependable dividends, and a larger investment pipeline, but also only moderate

Is Vita Coco Company (COCO) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is Vita Coco Company (COCO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Here is Why Growth Investors Should Buy SPX Technologies (SPXC) Now
Here is Why Growth Investors Should Buy SPX Technologies (SPXC) Now

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)
3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock

RDDT vs. AMZN: Which Digital Advertising Stock Is a Better Buy?
RDDT vs. AMZN: Which Digital Advertising Stock Is a Better Buy?

Reddit RDDT and Amazon AMZN are major players in the digital advertising space. While RDDT is an emerging social media platform gaining traction with community-driven advertising, Amazon continues

COIN Stock Up 29% in 3 Months But Valuation Expensive: How to Play
COIN Stock Up 29% in 3 Months But Valuation Expensive: How to Play

Shares of Coinbase Global COIN have gained 29.1% in the past three months, outperforming the industry, sector and the Zacks S&P 500 composite. Coinbase, a leading player in the crypto space, is

Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
Which Pharma Giant Offers Better Growth: AstraZeneca or AbbVie?

AstraZeneca AZN and AbbVie ABBV are leading U.S. drugmakers with strong positions in high-growth therapeutic areas like immunology and oncology.

For AstraZeneca, oncology represents about 44% of

Amphenol's Operating Margin Improves in Q1: Can It Expand Further?
Amphenol's Operating Margin Improves in Q1: Can It Expand Further?

Amphenol APH delivered a strong operating margin expansion in the first quarter of 2026. The company reported a non-GAAP operating margin of 27.3% for the first quarter, indicating a 380 basis

Safe Pro Group Inc. (SPAI) Reports Q1 Loss, Beats Revenue Estimates
Safe Pro Group Inc. (SPAI) Reports Q1 Loss, Beats Revenue Estimates

Safe Pro Group Inc. (SPAI) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.27 per share a year ago. These

Ampco-Pittsburgh Stock Slips Post Q1 Earnings Despite Sales Growth
Ampco-Pittsburgh Stock Slips Post Q1 Earnings Despite Sales Growth

Shares of Ampco-Pittsburgh Corporation AP have lost 3% since the company reported earnings for the quarter ended March 31, 2026, against the S&P 500 Index’s 1.3% gain over the same period. Over the

NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y
NeurAxis Stock Gains Post Q1 Earnings, Revenues and Margin Surge Y/Y

Shares of NeurAxis, Inc. NRXS have gained 2.5% since the company reported earnings for the quarter ended March 31, 2026, outperforming the S&P 500 Index’s 1.3% increase over the same period. Over

Par Pacific Shares Plunge 13% as Q1 Earnings Miss Estimates
Par Pacific Shares Plunge 13% as Q1 Earnings Miss Estimates

Par Pacific Holdings, Inc. PARR reported first-quarter 2026 results on May 5, 2026, after the closing bell. Following the announcement, the company’s share price declined 13% to $60.18 per share.

Surging Earnings Estimates Signal Upside for Ralliant (RAL) Stock
Surging Earnings Estimates Signal Upside for Ralliant (RAL) Stock

Ralliant (RAL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Earnings Estimates Moving Higher for Legacy Housing (LEGH): Time to Buy?
Earnings Estimates Moving Higher for Legacy Housing (LEGH): Time to Buy?

Legacy Housing (LEGH) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue

Why Vestis (VSTS) Might be Well Poised for a Surge
Why Vestis (VSTS) Might be Well Poised for a Surge

Vestis (VSTS) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with analysts

Will Cognex (CGNX) Gain on Rising Earnings Estimates?
Will Cognex (CGNX) Gain on Rising Earnings Estimates?

Cognex Corporation (CGNX) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue

Earnings Estimates Moving Higher for Aaon (AAON): Time to Buy?
Earnings Estimates Moving Higher for Aaon (AAON): Time to Buy?

Investors might want to bet on Aaon (AAON), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price momentum, and this

Earnings Estimates Moving Higher for Kulicke and Soffa (KLIC): Time to Buy?
Earnings Estimates Moving Higher for Kulicke and Soffa (KLIC): Time to Buy?

Investors might want to bet on Kulicke and Soffa (KLIC), as earnings estimates for this company have been showing solid improvement lately. The stock has already gained solid short-term price